[Hepatitis C virus-related hepatocellular carcinoma].
Sumi
H
H
Department of Medicine and Clinical Oncology, Graduate School of Medicine, Chiba University.
Yokosuka
O
O
D000970:Antineoplastic Agents / Q000627:therapeutic use; D006528:Carcinoma, Hepatocellular / Q000209:etiology* / Q000628:therapy / Q000821:virology; D017115:Catheter Ablation; D016461:Chemoembolization, Therapeutic; D000431:Ethanol / Q000008:administration & dosage; D006498:Hepatectomy; D006526:Hepatitis C / Q000150:complications* / Q000821:virology; D006801:Humans; D007372:Interferons / Q000627:therapeutic use; D008113:Liver Neoplasms / Q000209:etiology* / Q000628:therapy / Q000821:virology; D012176:Retinoids / Q000627:therapeutic use; D012307:Risk Factors
D000970:Antineoplastic Agents; D012176:Retinoids; D000431:Ethanol; D007372:Interferons